The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180, 34 -38
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, C. G.
Right arrow Articles by Choi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, C. G.
Right arrow Articles by Choi, Y.

Cutting Edge: Requirement for TRAF6 in the Induction of T Cell Anergy1

Carolyn G. King*, Jodi L. Buckler{dagger}, Takashi Kobayashi*, Jeffrey R. Hannah*, Garrett Bassett*, Taesoo Kim*, Erika L. Pearce*, Gregory G. Kim*, Laurence A. Turka{dagger} and Yongwon Choi2,*

* Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute and {dagger} Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

TRAF6, TNFR-associated factor 6, is a key adaptor downstream from the TNF receptor and TLR superfamily members. T cell-specific deletion of TRAF6 (TRAF6-{Delta}T) was recently shown to result in the development of multiorgan inflammatory disease and the resistance of responder T cells to suppression by CD4+CD25+ regulatory T cells. In this study we examined the role of TRAF6 in an additional mechanism of peripheral tolerance, anergy. We have determined that the loss of TRAF6 restores the ability of CD28–/– T cells to proliferate and produce IL-2. Consistent with this, TRAF6-{Delta}T T cells were resistant to anergizing signals both in vitro and in vivo. Resistance to anergy was correlated with decreased expression of Cbl-b. These findings reveal that in addition to its role in rendering T cells susceptible to control by CD4+CD25+ regulatory T cells, TRAF6 is essential for the induction of T cell anergy, implicating TRAF6 as a critical mediator of peripheral tolerance.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by National Institutes of Health Grant AI-43620 (to Y.C. and L.A.T.).

2 Address correspondence and reprint requests to Dr. Yongwon Choi, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Room 308, Biomedical Research Building II/III, 421 Curie Boulevard, Philadelphia, PA 19104-6144. E-mail address: ychoi3{at}mail.med.upenn.edu

3 Abbreviations used in this paper: TRAF6, TNFR-associated factor 6; SEB, staphylococcal enterotoxin B; TRAF6-{Delta}T, T cell-specific deletion of TRAF6.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Pierau, S. Engelmann, D. Reinhold, T. Lapp, B. Schraven, and U. H. Bommhardt
Protein Kinase B/Akt Signals Impair Th17 Differentiation and Support Natural Regulatory T Cell Function and Induced Regulatory T Cell Formation
J. Immunol., November 15, 2009; 183(10): 6124 - 6134.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Wells
New Insights into the Molecular Basis of T Cell Anergy: Anergy Factors, Avoidance Sensors, and Epigenetic Imprinting
J. Immunol., June 15, 2009; 182(12): 7331 - 7341.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Lamothe, A. D. Campos, W. K. Webster, A. Gopinathan, L. Hur, and B. G. Darnay
The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKL
J. Biol. Chem., September 5, 2008; 283(36): 24871 - 24880.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.